Sponsor pipeline

Menzies School of Health Research clinical trial pipeline

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

NCT ID	Title	Condition	Status	Updated
Phase 4
NCT07578298	THRIVE - Trial of Passive Humoral RSV Immunity for Value and Effectiveness	Respiratory Syncytial Virus (RSV)	Recruiting	2026-10-07
NCT07468513	Primaquine for Vivax Malaria in G6PD Intermediate and Deficient Cases.	Vivax Malaria	Recruiting	2026-03-12
NCT07060794	Tafenoquine and ACTs (TADORE- Plus)	Vivax Malaria	Not Yet Recruiting	2026-03-18
Phase 3
NCT06148792	A Revised Tafenoquine Dose to Improve Radical Cure for Vivax Malaria	Vivax Malaria	Recruiting	2025-07-18
NCT07468526	An Ultra-short Course of Primaquine for the Radical Cure of Vivax Malaria	Malaria	Not Yet Recruiting	2026-03-12
NCT05426434	Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine for Intermittent Preventive…	Malaria	Active, Not Recruiting	2025-06-06
Phase 2
NCT05629416	The Communicate Study Partnership	Aboriginal Health	Recruiting	2023-02-16

Get alerts when Menzies School of Health Research's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.